The Biotechnology sector is at the forefront of scientific innovation, developing breakthrough solutions in healthcare, agriculture, industrial processes, and environmental protection. The industry’s impact spans from revolutionary medical treatments to sustainable food production and biofuels. As of 2024, the global biotechnology market was valued at approximately $700 billion, with projections suggesting growth to reach $2.44 trillion by 2028. The sector’s contribution to global healthcare solutions became particularly evident during the COVID-19 pandemic through rapid vaccine development. The industry is driving economic growth through job creation, research and development investments, and technological innovations in areas such as gene therapy, personalized medicine, synthetic biology, and agricultural biotechnology.

The United States leads the sector with major companies like Amgen, Gilead Sciences, and Moderna, hosting about 40% of global biotech companies. Europe follows with strong presence in countries like Switzerland (Roche), Germany (BioNTech), and Denmark (Novo Nordisk). China is rapidly expanding its biotech capabilities, while South Korea and Japan maintain significant positions in the market.